| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/08/2001 | WO2000058475A3 Streptococcus pneumoniae antigens |
| 03/08/2001 | WO2000057184A3 Screening methods based on fha domains |
| 03/08/2001 | WO2000044902A3 Biomarkers and assays for carcinogenesis induced by phenobarbitol |
| 03/08/2001 | WO2000041546A9 Novel exendin agonist formulations and methods of administration thereof |
| 03/08/2001 | WO2000039342A3 Use of essential saccharomyces genes and polypeptides |
| 03/08/2001 | WO2000026246A9 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof |
| 03/08/2001 | WO2000023588A8 G-protein coupled receptors |
| 03/08/2001 | WO2000020447A8 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses |
| 03/08/2001 | WO2000012736A9 A new method of identifying non-host plant disease resistance genes |
| 03/08/2001 | WO1999058663A9 METHODS AND COMPOSITIONS FOR SCREENING FOR MODULATORS OF IgE SYNTHESIS, SECRETION AND SWITCH REARRANGEMENT |
| 03/08/2001 | DE19943721A1 New 14113 T variant of the c-myb gene, useful as a target for diagnosing or assessing the risk of proliferative diseases |
| 03/08/2001 | DE19943702A1 New peptides that stimulate cytokine production in T cells, useful for vaccination against human cytomegalovirus infection and for detecting immune responses to the virus |
| 03/08/2001 | DE19941478A1 Neue für das thrE-Gen codierende Nukleotidsequenzen und Verfahren zur fermentativen Herstellung von L-Threonin mit coryneformen Bakterien New coding for the thrE gene nucleotide sequences and processes for the fermentative preparation of L-threonine with coryneform bacteria |
| 03/08/2001 | DE19938390A1 Neue Sequenzvarianten des menschlichen ßl-Adrenozeptorgens und ihre Verwendung New sequence variants of the human ßl-Adrenozeptorgens and their use |
| 03/08/2001 | CA2645727A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/08/2001 | CA2481788A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/08/2001 | CA2481756A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/08/2001 | CA2481691A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/08/2001 | CA2481685A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/08/2001 | CA2391868A1 Novel g protein-coupled receptor protein and dna thereof |
| 03/08/2001 | CA2388734A1 37 staphylococcus aureus genes and polypeptides |
| 03/08/2001 | CA2387711A1 Novel g protein-coupled receptor protein and dna thereof |
| 03/08/2001 | CA2384055A1 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | CA2384026A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 03/08/2001 | CA2383877A1 Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein |
| 03/08/2001 | CA2383784A1 Apoptin-associating protein |
| 03/08/2001 | CA2383693A1 Card proteins involved in cell death regulation |
| 03/08/2001 | CA2383606A1 Iren protein, its preparation and use |
| 03/08/2001 | CA2383564A1 Transgenic animal model for neurodegenerative diseases |
| 03/08/2001 | CA2383557A1 Vaccine antigens of moraxella |
| 03/08/2001 | CA2383411A1 Hepatitis c virus replication inhibitors |
| 03/08/2001 | CA2383381A1 Methods and compositions relating to body weight and eating disorders |
| 03/08/2001 | CA2383367A1 Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2 |
| 03/08/2001 | CA2383358A1 Methods and compositions of a novel serine protease inhibitor |
| 03/08/2001 | CA2383047A1 Effect of steroids on nmda receptors depends on subunit composition |
| 03/08/2001 | CA2382989A1 Materials and methods for inhibition of ige production |
| 03/08/2001 | CA2382952A1 Induction of programmed cell death by n5 gene |
| 03/08/2001 | CA2382890A1 Gene coding for protein involved in cytokinin signal transduction |
| 03/08/2001 | CA2382889A1 Novel g protein-coupled receptor protein and dna thereof |
| 03/08/2001 | CA2382812A1 Crystal structures of domains of receptor protein tyrosine kinases and their ligands |
| 03/08/2001 | CA2382622A1 Polycyclic aromatic hydrocarbon induced molecules |
| 03/08/2001 | CA2382562A1 Compositions and methods for modulating hdl cholesterol and triglyceride levels |
| 03/08/2001 | CA2382499A1 Method for coupling molecules |
| 03/08/2001 | CA2382383A1 Transgenic mammal capable of facilitating production of donor-specific functional immunity |
| 03/08/2001 | CA2382381A1 Pa28 modified transgenic mice |
| 03/08/2001 | CA2382030A1 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 03/08/2001 | CA2382026A1 Vaccine to control equine protozoal myeloencephalitis in horses |
| 03/08/2001 | CA2381451A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 03/08/2001 | CA2381139A1 Method for the production of a channel forming protein |
| 03/08/2001 | CA2380355A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/08/2001 | CA2379994A1 Plant reproduction proteins |
| 03/08/2001 | CA2348158A1 Modified adenoviral fibre and uses thereof |
| 03/07/2001 | EP1081231A1 Method for recovering soluble protein |
| 03/07/2001 | EP1081226A1 Apoptin-associating protein |
| 03/07/2001 | EP1081225A1 Transgenic animal model for neurodegenerative diseases |
| 03/07/2001 | EP1081224A1 Novel method for isolating gene |
| 03/07/2001 | EP1081223A1 Promoter sequences expressed in anthers and pollens |
| 03/07/2001 | EP1081159A1 Purified human activin and process for producing the same |
| 03/07/2001 | EP1080371A1 Method and means for caries prevention and susceptibility detection |
| 03/07/2001 | EP1080233A1 Compounds, screening methods, and uses involving anti-apoptotic genes and gene products |
| 03/07/2001 | EP1080232A2 MarA FAMILY HELIX-TURN-HELIX DOMAINS AND THEIR METHODS OF USE |
| 03/07/2001 | EP1080216A2 Retroviral delivery system |
| 03/07/2001 | EP1080214A2 Cotton cells, plants, and seeds genetically engineered to express insecticidal and fungicidal chitin binding proteins (lectins) |
| 03/07/2001 | EP1080212A1 Control of sporocyte or meiocyte formation in plants |
| 03/07/2001 | EP1080211A1 Method of producing thy-a-deficient strains of vibrio cholerae, such strains and their use |
| 03/07/2001 | EP1080206A1 Generation of multiple gene products from chimeric fusion proteins by cleavage with ubiqitous endoproteases |
| 03/07/2001 | EP1080200A1 Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4 |
| 03/07/2001 | EP1080199A2 (hemorrhagic enteritis) virus dna sequences, proteins encoded thereby and various uses thereof |
| 03/07/2001 | EP1080198A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| 03/07/2001 | EP1080197A2 Cell cycle genes, proteins and uses thereof |
| 03/07/2001 | EP1080196A1 Polynucleotide sequences and their use in a method of producing plants with an increased number of stomata |
| 03/07/2001 | EP1080195A1 Endometriosis-associated gene |
| 03/07/2001 | EP1080194A2 Human transmembrane proteins |
| 03/07/2001 | EP1080193A2 Multivalent t cell receptor complexes |
| 03/07/2001 | EP1080191A1 Insect control gene dsf and methods of use |
| 03/07/2001 | EP1080190A1 Calmodulin related protein |
| 03/07/2001 | EP1080188A2 Human nucleic acid sequences of uterus myoma tissue |
| 03/07/2001 | EP1080187A2 Modification of cereal grain hardness via expression of puroindoline proteins |
| 03/07/2001 | EP1080186A2 Method for altering the activity of proteins of the pka signaling pathway |
| 03/07/2001 | EP1080185A2 Myelin basic protein peptides and uses thereof |
| 03/07/2001 | EP1080182A1 Amino acid modified polypeptides |
| 03/07/2001 | EP1080180A2 Secreted proteins and polynucleotides encoding them |
| 03/07/2001 | EP1080158A1 Adhesives |
| 03/07/2001 | EP1080112A1 Method for separating and/or isolating plasma proteins by annularchromatography |
| 03/07/2001 | EP1080111A2 The induction of antiobiotic peptides by lait (scd14) protein |
| 03/07/2001 | EP1080110A2 Use of activated t cells, nervous system-specific antigens for treating disorders of the nevrous system |
| 03/07/2001 | EP1080109A1 Method for purification of borrelia lipoprotein ospa |
| 03/07/2001 | EP1080108A1 Cytokine resistant cytomegalovirus promoter mutants and related products and methods |
| 03/07/2001 | EP1080107A2 Novel (poly)peptides which represent the epitopes of the human herpes virus type 8 |
| 03/07/2001 | EP1080106A1 Secreted proteins and polynucleotides encoding them |
| 03/07/2001 | EP1080102A1 Antigens and their detection |
| 03/07/2001 | EP1079866A2 Methods of inhibiting clot formation |
| 03/07/2001 | EP1079861A1 Regulation of biofilm formation |
| 03/07/2001 | EP1079860A1 Nicotine immunogen |
| 03/07/2001 | EP1079858A2 Oral immunization with papillomavirus virus-like particles |
| 03/07/2001 | EP1079851A1 Use of anti-prolactin agents to treat proliferative conditions |
| 03/07/2001 | EP1079850A1 Compound delivery using rapidly dissolving collagen film |
| 03/07/2001 | EP1079849A2 Use of hmg proteins for the preparation of medicaments having cytotoxic activity |
| 03/07/2001 | EP1079848A1 Angiostatin receptor |
| 03/07/2001 | EP1079847A2 Osteoporosis treatment |